Ali Al-Ghanim Sons Automotive Company K.S.C.P. (KWSE:ALG)

Aerovate Therapeutics Balance Sheet

Financials in millions KWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	20.29	16.67	18.98	14.91	19.07	22.5
Short-Term Investments	-	0.2	1.5	1	-	-
Cash & Short-Term Investments	20.29	16.86	20.48	15.91	19.07	22.5
Cash Growth	12.78%	-17.67%	28.74%	-16.57%	-15.26%	193.89%
Accounts Receivable	21.81	7.81	6.27	5.61	5.92	7.97
Other Receivables	-	8.55	7.61	6	0.58	1.18
Receivables	21.81	16.36	13.88	11.62	6.51	9.15
Inventory	85.35	92.9	63.29	52.35	24.09	30.09
Prepaid Expenses	-	1.09	0.9	0.54	0.46	0.53
Other Current Assets	-	0.62	0.76	1.25	4.03	0.36
Total Current Assets	127.44	127.83	99.31	81.66	54.14	62.63
Property, Plant & Equipment	120.78	119.35	109.95	101.72	91.98	103.2
Long-Term Investments	24.73	15.49	12.87	3.53	0.25	0.42
Other Intangible Assets	0.14	0.13	0.08	0.22	0.33	0.35
Long-Term Accounts Receivable	0.67	0.17	0.72	0.95	1.38	0.33
Other Long-Term Assets	-	0.25	0.25	-	-	-
Total Assets	273.76	263.21	223.18	188.08	148.09	166.93
Accounts Payable	60.87	53.62	30.6	36.92	17.48	29.9
Accrued Expenses	-	12.89	12.6	8.18	7.48	4.03
Short-Term Debt	-	11.9	9.56	4.27	-	-
Current Portion of Long-Term Debt	27.01	9.25	4.46	2.62	2.25	10.59
Current Portion of Leases	-	2.42	2.18	1.47	1.37	1.26
Current Unearned Revenue	-	4.38	4.15	3.21	3.85	3.74
Other Current Liabilities	11.03	10.96	15.94	20.33	18.16	7.69
Total Current Liabilities	98.92	105.42	79.48	77	50.59	57.2
Long-Term Debt	37.96	31.64	29.05	13.98	19.98	26.93
Long-Term Leases	-	5.67	5.05	3.87	2.72	3.24
Long-Term Unearned Revenue	-	12.34	9.29	7.9	5.98	4.87
Other Long-Term Liabilities	20.28	2.49	2.04	0.21	0.14	0.14
Total Liabilities	163.63	163.81	130.75	108.41	84.12	96.84
Common Stock	36.08	27.75	27.75	27.75	27.75	17.75
Additional Paid-In Capital	0.77	0.01	0.01	0.01	-	-
Retained Earnings	33.75	36.19	26.11	16.54	9.25	19.76
Treasury Stock	-2.24	-3.14	-3.01	-2.95	-	-
Comprehensive Income & Other	28.28	28.02	31.68	31.63	20.34	25.63
Total Common Equity	96.63	88.83	82.53	72.96	57.34	63.14
Minority Interest	13.49	10.57	9.9	6.7	6.63	6.95
Shareholders' Equity	110.13	99.4	92.43	79.67	63.97	70.09
Total Liabilities & Equity	273.76	263.21	223.18	188.08	148.09	166.93
Total Debt	64.98	60.89	50.3	26.22	26.32	42.02
Net Cash (Debt)	-44.69	-44.03	-29.82	-10.31	-7.25	-19.51
Net Cash Per Share	-0.13	-0.12	-0.08	-0.03	-0.02	-0.08
Filing Date Shares Outstanding	357.33	356.03	356.19	356.26	360.75	230.75
Total Common Shares Outstanding	357.33	356.03	356.19	356.26	360.75	230.75
Working Capital	28.53	22.41	19.84	4.65	3.55	5.43
Book Value Per Share	0.27	0.25	0.23	0.20	0.16	0.27
Tangible Book Value	96.5	88.7	82.46	72.74	57.02	62.79
Tangible Book Value Per Share	0.27	0.25	0.23	0.20	0.16	0.27
Land	-	72.64	72.64	72.64	61.27	66.27
Buildings	-	27.09	27.07	27.07	27.06	27.99
Machinery	-	40.61	34.13	26.73	28.03	30.97
Construction In Progress	-	3.01	0.04	0.63	0.04	0.25

Source: S&P Global Market Intelligence. Standard template. Financial Sources.